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Abstract 
BACKGROUND: Anaphylaxis often misdiagnosed and treated as acute asthma, especially when it has a 
predominant respiratory symptom, and there are no obvious precipitants or previous allergic history. This morbid 
outcome is preventable if the level of suspicion for anaphylaxis is high among healthcare provider when treating a 
patient who is not responding to the standard management of acute asthma. A proportion of anaphylactic patient 
shows a biphasic reaction which potentially fatal when it is under-anticipated and prematurely discharge without 
adequate observation period after the recovery of the initial episode.  
CASE REPORT: Here, we present a case of a young man who has childhood asthma with the last attack more 
than 10 years ago presented with symptoms suggestive of acute exacerbation of bronchial asthma. As the 
symptoms failed to improve after standard asthma management, anaphylaxis was suspected, and he was given 
intramuscular adrenaline 0.5 mg which leads to symptom improvement. However, he developed another attack 
shortly after improvement while under observation.  
CONCLUSION: The objective of this case report is to emphasise the importance of keeping anaphylaxis in mind 
whenever a patient has treatment-refractory asthma, and also the anticipation of biphasic reaction that warrants 
adequate observation period especially those who are likely to have developed it. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Acute asthma and anaphylactic reaction have 
a clinical presentation that similar to each other. 
Therefore, it is not uncommon for a patient with 
anaphylaxis to be treated as acute asthma and not 
given the appropriate treatment [1]. This potentially 
fatal misdiagnosis can be prevented if health care 
provider has a higher suspicion level for anaphylaxis 
when treating an acute asthma patient that refractory 
to standard treatment. Biphasic anaphylaxis is one of 
the morbid sequelae of an anaphylactic reaction, 
which is still poorly understood and said to occur in 1 
in every 5 cases of anaphylaxis [2]. The fatality of this 
phenomenon can be avoided if the patient is 
subjected to adequate observation after the recovery 
of the initial symptoms, especially those who have a 
history of bronchial asthma or another risk factor.  
 
 
Case Report 
 
A 21-year old army officer presented with 
progressive shortness of breath and left-sided pleuritic 
chest pain for the past three days. He had a fever with 
coryzal symptoms five days before the onset of 
breathlessness which he seeks treatment from a 
private clinic. He has given oral amoxicillin 500 mg 
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three times daily, oral chlorpheniramine 4 mg three 
times daily, oral paracetamol 1gm four times daily and 
oral salbutamol 2 mg three times daily. He was also 
nebulised twice during the clinic visit. There was no 
spirometry test done during the visit. Upon further 
history noted that he had childhood asthma before 
and was only on a single short-acting reliever 
treatment with salbutamol inhaler, and never had a 
proper follow-up. The last asthma attack was more 
than 10 years ago. On arrival to the emergency 
department, he was tachypnoeic and had multiple 
bouts of a cough, but otherwise alert and conscious. 
There was a marked periorbital swelling noted as well. 
According to the patient, he noticed that his face was 
increasing swollen in the past few days, and there 
were some itchiness and redness too, but he did not 
seek any treatment for it. He was allergic to cashew 
nuts and diclofenac which he did not take before the 
complaint. His vital signs were stable with a blood 
pressure of 130/90 mmHg, heart rate of 140 beats per 
minute and oxygen saturation rate of 100% on room 
air via a pulse oximeter. On examination of the chest 
noted there was a very poor air entry over the whole 
both lungs with occasional rhonchi heard. Preliminary 
blood investigation was taken (as shown in Table 1). 
His chest radiograph image did not show 
pneumothorax or consolidation (as shown in Figure 
1).  
Table 1: Preliminary blood investigation taken on arrival to the 
emergency department showed mild leucocytosis and 
eosinophilia. Otherwise the haemoglobin and platelet count 
was normal. There is no deranged electrolyte level, and no liver 
or renal impairment 
TEST VALUE NORMAL RANGE 
Haemoglobin 14.1 g/d 12 – 18 g/dL 
Haematocrit 43.5 % 35 – 48 % 
White cell count 11.8 x 10
9
/L 4.0 – 11.0 x 10
9
/L 
Eosinophil 0.6 x 10
9
/L 0.2 – 0.5 x 10
9
/L 
Platelet 294 x 10
9
/L 150 – 400 x 10
9
/L 
Urea 5.4 mmol/L 1.7 – 8.0 mmol/L 
Creatinine 104 umol/L 60 – 120 umol/L 
Sodium 138 mmol/L 135 – 150 mmol/L 
Potassium 3.9 mmol/L 3.5 – 5.0 mmol/L 
Calcium 2.3 mmol/L 2.10 – 2.55 mmol/L 
Magnesium 0.90 mmol/L 0.75 – 1.10 mmol/L 
ALT 42 u/L 5 – 35 u/L 
ALP 70 u/L 30 – 100 u/L 
pH 7.38 7.35 – 7.45 
Arterial PaO2 82 mmHg 80 - 100 mmHg 
PaCO2 40 mmHg 35 – 45 mmHg 
HCO3
-
 26 mEq/L 22 – 28 mEq/L 
ALT: Alanine Aminotransferase; ALP: Alkaline Phosphatase; PaO2: Partial Pressure of 
Oxygen; PaCO2: Partial Pressure of Carbon Dioxide; HCO3
-
: Bicarbonate  
 
Given the symptoms and the background 
history of childhood asthma, the initial impression was 
severe to life-threatening acute exacerbation of 
bronchial asthma. He was immediately given multiple 
nebulizations of combined salbutamol and ipratropium 
bromide along with intravenous (IV) hydrocortisone 
200 mg bolus, IV chlorpheniramine 10 mg bolus, and 
IV magnesium sulphate 2.47 mg slow infusion. 
Despite all the medications, the patient still has severe 
bronchospasm and worsening tachypnoea.  
At this point, the possibility of severe 
anaphylaxis was entertained given the facial swelling 
and itchiness, and also the symptoms were refractory 
to the standard bronchodilator management. 
 
Figure 1: Chest radiograph image taken on arrival to the emergency 
department was normal 
 
It could be secondary to the antibiotic he took 
a few days ago or may be triggered by recent upper 
respiratory tract infection. Therefore, intramuscular 
(IM) adrenaline 0.5 mg was given, and it provides 
rapid improvement. However, it only provides a 
temporary relief whereby the bronchospasm and 
tachypnoea resumed and necessitates a repeated IM 
adrenaline to be given twice. The facial swelling 
reduced but the bronchospasm persisted. Repeated 
arterial blood gas at that time showed type 1 
respiratory failure with the slow rising of carbon 
dioxide retention. The nebulization was escalated to 
continuous nebulization. As the patient was 
increasingly fatigue and there were impending type 2 
respiratory failures, the patient was subjected to 
invasive assisted ventilation. While intubated and 
mechanically ventilated, the bronchodilator nebuliser 
was continued. After being on assisted ventilation for 
12 hours, he was then extubated and kept on closed 
observation in the intensive care unit. He managed to 
keep good oxygenation via spontaneous respiratory 
effort, and there was no further bronchospasm attack. 
He was discharged after a few days of admission with 
an emergency epinephrine pen and will be 
investigated for the potential triggers of his 
anaphylaxis episode in the outpatient clinic 
appointment. Spirometry test done before discharge 
was normal. 
 
 
Discussion 
 
Anaphylaxis is an acute, systemic, potentially 
fatal allergic reaction which driven by type I 
hypersensitivity reaction that requires both immediate 
recognition and rapid treatment. It is clinically 
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manifested as hives, flushing, itchiness, angioedema, 
wheezing, stridor, breathlessness, vomiting, diarrhoea 
or shock. Given the nature of its presentation, 
anaphylaxis with respiratory symptom predominant 
can be easily misdiagnosed as severe acute asthma. 
According to an original article by J. Rainbow and G.J. 
Browne (2002), patients who have the symptom of 
severe acute asthma may be suffering from 
anaphylaxis. Therefore, they mentioned a few 
recommendations, which are to suspect anaphylaxis 
in a patient with rapid onset of wheeze or not 
responding to the standard asthma treatment, to use 
adrenaline early when anaphylaxis is suspected, to 
confirmed anaphylaxis with radioimmunoassay and 
mast cell tryptase level, and to screen for precipitating 
allergens [1]. 
Some patient with anaphylaxis may show a 
biphasic reaction. Biphasic anaphylaxis refers to the 
second episode of anaphylaxis that follows the brief 
resolution of symptoms period after the initial 
anaphylaxis reaction without further exposure to the 
triggering factors. It is a poorly understood allergic 
phenomenon that has a fatal outcome and has been 
reported to develop in up to 20% of all cases of 
anaphylactic reactions [2]. There are a few possible 
risk factors has been suggested that increases the 
likelihood of biphasic anaphylaxis, namely severe 
initial symptoms, delayed administration of adrenaline 
during the initial treatment, a longer time for the initial 
reaction to resolve, delayed onset of the initial 
symptoms after exposure to the antigen, and 
exposure to allergens in the form of oral ingestion [3]. 
However, all these factors are still yet to be proven 
further by more study in the future. Confino-Cohen R 
and Goldberg A (2010) in their research of biphasic 
reactions following allergen immunotherapy 
suggested that the only difference between biphasic 
and uniphasic reactions was that a higher incidence of 
asthma and low peak expiratory flow rate could be 
identified in those with biphasic reactions [4]. The 
clinical severity of the second phase of biphasic 
anaphylaxis does not necessarily resemble the first. 
Some reported that it could be more severe or even 
fatal [5]. The period between the recurrence of 
symptoms and the initial resolution of initial symptom 
varies substantially and can go up to 72 hours. 
In this article, our patient presented with 
symptoms of severe to life-threatening acute 
exacerbation of bronchial asthma. After treated 
promptly with bronchodilator nebuliser and other 
systemic medications, the bronchospasm failed to 
improve. Therefore, given the presence of a history of 
allergy and also taking antibiotic before the 
presentation, there was a possibility of severe 
anaphylaxis instead of acute asthma which may be 
induced by the antibiotic. Therefore, intramuscular 
(IM) adrenaline 0.5 mg was given, and it leads to rapid 
improvement. However, the patient showed a biphasic 
anaphylactic reaction whereby there was only a brief 
period where the bronchospasm and facial swelling 
improved after the first dose of IM adrenaline before 
the bronchospasm recur again while he was under 
observation, which severe enough that he needs to be 
intubated and mechanically ventilated. 
In conclusion, this case report served to 
emphasise the importance of having a high level of 
suspicion for severe anaphylaxis whenever treating a 
non-responsive life-threatening bronchial asthma. 
Therefore, it is imperative to give a trial of adrenaline 
in a severe to life-threatening acute asthma patient 
who is refractory to standard treatment, with or without 
allergy history. Apart from that, it is also crucial to 
anticipate a biphasic reaction in a patient with a high 
likelihood to develop it, for example, who has 
underlying bronchial asthma. Therefore, a period of 
observation after the resolution of attack is warranted 
and potentially save a life. 
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